Kisqali 200 MG daily dose UU 21S
Ended Awarded
- Contract number
- SPE2DR26F4Q7P
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,917
Award facts
- Contract value 100% obligated
- $4,916.62 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $4,916.62 delivery order to AmerisourceBergen Drug Corp on July 17, 2026, for Kisqali 200 mg daily dose tablets.
Place of performance is Conshohocken, PA. The order has an ultimate completion date of August 7, 2026, and is priced on a firm fixed-price basis with no set-aside.
Quick answers
Who was awarded contract SPE2DR26F4Q7P?
SPE2DR26F4Q7P was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 17, 2026.
How much is contract SPE2DR26F4Q7P worth?
The government has obligated $4,917 on SPE2DR26F4Q7P.
Is contract SPE2DR26F4Q7P an order under another contract?
Yes. SPE2DR26F4Q7P is a delivery order under SPE2DR25D3012, an indefinite delivery contract.
Was contract SPE2DR26F4Q7P competed?
The extent of competition for SPE2DR26F4Q7P was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award